A study has found that there are similar safety profiles for -blockers and verapamil in patients with low-risk hypertrophic ...

Initiation or switching β blockers is not recommended in patients experiencing a severe decompensation of HF (e.g., requiring intravenous positive inotropic agents, vasodilators, or mechanical ...

A well-studied, widely used class of drugs for heart health may have benefits for Huntington’s disease. A new paper ...

However, β blockers do not all share the same clinical ... and a β 1-selective agent (e.g., metoprolol, atenolol) are described to simplify the process and maximize the safety and tolerability ...

Beta-blockers are now a worldwide mainstay of heart failure treatment recommended in all international guidelines for chronic heart failure Beta-blockers are now a worldwide mainstay of heart failure ...

Often used as a hypertension treatment drug, beta blockers may also be prescribed in cases of coronary artery disease, congestive heart failure, cardiac arrhythmias, and more, according to StatPearls.

Beta blockers are commonly prescribed after a heart attack to help prevent future heart problems. These medications work by ...

mrc.ac.za Beta-blockers refer to an assorted group of medications that block the action of endogenous catecholamines on beta-adrenergic receptors.1 The β1 and β2 receptors are the primary ...

Current guidelines regarding beta-blocker use after myocardial infarction (MI) recommend against continuation to improve outcomes after 1 year, in the absence of reduced left ventricular ejection ...

Long-term treatment with beta-blockers may not lower the risk of death or myocardial infarction (MI) in patients with MI, a preserved left ventricular ejection fraction (LVEF) of ≥50% and coronary ...